GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Fuji Pharma Co 4554.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

1,835

+3.21%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2025

Revenue

¥51.68bn

FY2016FY2025

Net income

¥3.00bn

FY2016FY2025

Free cash flow

¥3.82bn

FY2016FY2025

Shareholders' equity

¥46.91bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue¥51.68bn¥46.14bn¥40.89bn¥35.43bn¥33.99bn¥33.79bn¥36.28bn¥37.91bn¥35.39bn¥34.23bn
Gross profit¥19.29bn¥16.51bn¥15.37bn¥13.62bn¥14.13bn¥14.25bn¥15.18bn¥15.21bn¥14.00bn¥12.82bn
Research and development¥3.34bn¥3.40bn¥3.18bn¥2.48bn¥2.45bn¥3.06bn¥2.05bn¥1.76bn¥1.82bn¥1.84bn
Operating income¥4.99bn¥3.88bn¥3.86bn¥3.78bn¥3.40bn¥3.14bn¥4.17bn¥4.43bn¥4.35bn¥3.57bn
Net income¥3.00bn¥6.15bn¥3.44bn¥2.70bn¥2.43bn¥2.08bn¥2.96bn¥3.37bn¥3.30bn¥2.12bn
Diluted earnings per share122.67252.73141.33111.01100.1366.9195.08112.69110.2870.79

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets¥93.63bn¥90.58bn¥86.40bn¥75.54bn¥64.24bn¥61.96bn¥60.74bn¥53.12bn¥49.55bn¥48.15bn
Cash and short-term investments¥7.25bn¥4.58bn¥2.32bn¥3.55bn¥10.20bn¥12.04bn¥8.49bn¥6.25bn¥5.50bn¥6.82bn
Total liabilities¥46.72bn¥45.01bn¥45.22bn¥39.73bn¥31.56bn¥22.00bn¥21.37bn¥17.77bn¥16.95bn¥18.92bn
Debt¥30.94bn¥29.25bn¥28.95bn¥24.69bn¥18.82bn¥12.35bn¥11.07bn¥5.24bn¥5.04bn¥7.09bn
Shareholders' equity¥46.91bn¥45.56bn¥41.17bn¥35.80bn¥32.68bn¥39.96bn¥39.36bn¥35.35bn¥32.60bn¥29.22bn
Shares outstanding24m24m24m24m24m31m31m30m30m30m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations¥5.80bn¥4.15bn¥1.92bn−¥658.0m¥5.99bn¥5.77bn¥7.04bn¥3.77bn¥3.24bn¥4.51bn
Capital spending−¥1.98bn−¥2.78bn−¥3.90bn−¥12.42bn−¥3.90bn−¥2.62bn−¥1.70bn−¥1.45bn−¥1.48bn−¥2.31bn
Free cash flow¥3.82bn¥1.37bn−¥1.98bn−¥13.08bn¥2.10bn¥3.15bn¥5.33bn¥2.33bn¥1.76bn¥2.20bn
Dividends paid−¥1.04bn−¥972.0m−¥899.0m−¥729.0m−¥807.0m−¥904.0m−¥839.0m−¥794.0m−¥704.0m−¥674.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥15.67bn¥13.82bn¥15.90bn¥14.72bn¥12.86bn¥11.10bn¥13.00bn¥12.98bn
Gross profit¥5.33bn¥5.51bn¥6.82bn¥6.01bn¥4.86bn¥4.58bn¥5.21bn¥5.25bn
Operating income¥995.0m¥1.61bn¥2.79bn¥1.62bn¥1.06bn¥1.05bn¥1.25bn¥1.66bn
Net income¥1.11bn¥389.0m¥324.0m¥1.17bn¥543.0m¥296.0m¥991.0m¥1.24bn
Diluted earnings per share42.3814.8913.2547.8422.2012.1040.7450.86
Cash from operations———¥5.80bn————
Capital spending———−¥1.98bn————
Free cash flow———¥3.82bn————
Total assets¥98.43bn¥97.94bn¥95.08bn¥93.63bn¥93.51bn¥92.67bn¥94.26bn¥90.58bn
Cash and short-term investments¥9.95bn¥10.89bn¥3.39bn¥7.25bn¥6.91bn¥6.70bn¥3.70bn¥4.58bn
Debt¥17.79bn¥25.79bn¥18.12bn¥26.82bn¥17.97bn¥27.95bn¥24.62bn¥22.97bn
Shareholders' equity¥51.88bn¥51.36bn¥47.95bn¥46.91bn¥45.52bn¥45.73bn¥47.76bn¥45.56bn

Financial ratios

Data as of 15 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin37.3%35.8%37.6%38.4%41.6%42.2%
Operating margin9.7%8.4%9.4%10.7%10.0%9.3%
Net margin5.8%13.3%8.4%7.6%7.2%6.2%
Return on equity6.4%13.5%8.3%7.5%7.4%5.2%
Return on assets3.2%6.8%4.0%3.6%3.8%3.4%
Free cash flow yield18.1%16.2%13.6%27.6%23.2%15.3%
Revenue growth12.0%12.8%15.4%4.2%0.6%-6.9%
Earnings growth-51.2%79.0%27.4%10.9%16.6%-29.6%
Current ratio1.55x1.19x1.31x1.45x1.73x3.18x
Debt to equity0.57x0.54x0.62x0.62x0.49x0.27x
Equity ratio50.1%50.3%47.7%47.4%50.9%64.5%
Interest coverage15.12x19.80x31.89x49.06x64.19x84.86x
R&D as a share of sales6.5%7.4%7.8%7.0%7.2%9.1%
Buybacks as a share of market value-0.5%-0.1%-0.0%-0.0%22.1%-0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue13.4%8.9%5.0%
Operating income9.7%9.7%4.4%
Net income3.6%7.5%3.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin36.6%37.2%38.5%39.0%
Operating margin9.1%9.5%9.5%10.3%
Net margin9.4%8.8%8.2%8.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings15.46.312.39.210.318.614.115.719.719.1
Price to sales0.90.81.00.70.71.11.11.41.81.2

Dividends and splits

Per share, in the currency the company pays

Paid for 15 years. Last went ex-dividend on 29 Sept 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year69.5042.5040.0037.0030.0029.0029.0028.00
  • 2-for-1 split · 27 Jun 2018

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.